Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck KGAA's Hostile Bid Catalyzes Bayer-Schering Combo

Apr 01 2006

Related Content

Schering: Addressing the Specialist Challenge

Nov 01 2004

The Best Defense Is a Good Offense: Sanofi's Bid for Aventis

Feb 01 2004

The Anti-Global, Specialist Strategy: Why Bayer's Choice Might Be Right for Other Pharmas

Jan 01 2005

Will Pharma Split Spur Altana Into Action?

Oct 01 2005

Bayer Wins Specialty CV Deal

Feb 01 2006

Related Companies

Bayer AG

Merck KGaA

Bayer AG

Sanofi

Onyx Pharmaceuticals, Inc.

Pfizer Inc.

Altana AG

Merck KGaA

GSK plc

Novartis AG

Schering-Plough

Additional Topics

Strategy Business Strategies Leadership BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window